• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫接种在何时、何地以及如何会失败?

When, where, and how do immunizations fail?

作者信息

Hinman A R, Orenstein W A, Mortimer E A

机构信息

Center for Prevention Services, Centers for Disease Control, Atlanta, GA 30333.

出版信息

Ann Epidemiol. 1992 Nov;2(6):805-12. doi: 10.1016/1047-2797(92)90074-z.

DOI:10.1016/1047-2797(92)90074-z
PMID:1342333
Abstract

There are two main reasons for failure of immunizations: (1) failure of the vaccine delivery system to provide potent vaccines properly to persons in need; and (2) failure of the immune response, whether due to inadequacies of the vaccine or factors inherent in the host. The first category is by far the most important worldwide. The major factor contributing to failure of the delivery system is failure to vaccinate; in the developing world this is commonly a result of inadequacy of the vaccine supply. Other important factors include barriers to immunizations, improper use of vaccines, vaccine ineffectiveness at the time of use, and factors relating to client attitudes and knowledge. Failure of the immune response may be either primary or secondary (loss of protection after initial effectiveness). The shortcomings of existing vaccines must not deter us from taking maximal advantage of their benefits.

摘要

免疫接种失败主要有两个原因

(1)疫苗接种系统未能将有效的疫苗正确地提供给有需要的人群;(2)免疫反应失败,这可能是由于疫苗本身的不足或宿主内在的因素所致。到目前为止,在全球范围内,第一类原因是最重要的。导致接种系统失败的主要因素是未能进行疫苗接种;在发展中世界,这通常是疫苗供应不足的结果。其他重要因素包括免疫接种的障碍、疫苗的不当使用、使用时疫苗无效以及与受种者态度和知识相关的因素。免疫反应失败可能是原发性的,也可能是继发性的(初始有效后失去保护作用)。现有疫苗的缺点不应阻碍我们最大限度地利用其益处。

相似文献

1
When, where, and how do immunizations fail?免疫接种在何时、何地以及如何会失败?
Ann Epidemiol. 1992 Nov;2(6):805-12. doi: 10.1016/1047-2797(92)90074-z.
2
Challenges for nationwide vaccine delivery in African countries.非洲国家全国范围疫苗接种面临的挑战。
Int J Health Econ Manag. 2018 Jun;18(2):197-219. doi: 10.1007/s10754-017-9229-5. Epub 2017 Oct 19.
3
Strategies for increasing adolescent immunizations in diverse ethnic communities.增加不同族裔社区青少年免疫接种的策略。
J Adolesc Health. 2015 May;56(5 Suppl):S47-53. doi: 10.1016/j.jadohealth.2014.10.274.
4
Primary vaccine failure to routine vaccines: Why and what to do?常规疫苗的原发性疫苗失败:原因及应对措施?
Hum Vaccin Immunother. 2016;12(1):239-43. doi: 10.1080/21645515.2015.1093263.
5
Primary care physician perspectives on reimbursement for childhood immunizations.基层医疗医生对儿童免疫接种报销的看法。
Pediatrics. 2008 Dec;122(6):1319-24. doi: 10.1542/peds.2008-2033.
6
A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination.细胞培养衍生的全病毒 H5N1 疫苗可诱导小鼠产生持久的跨谱系保护免疫,同源或异源加强免疫可增强这种免疫。
Vaccine. 2012 Aug 10;30(37):5533-40. doi: 10.1016/j.vaccine.2012.06.043. Epub 2012 Jun 29.
7
Immunological considerations regarding parental concerns on pediatric immunizations.关于家长对儿童免疫接种担忧的免疫学考量
Vaccine. 2017 May 25;35(23):3012-3019. doi: 10.1016/j.vaccine.2017.04.030. Epub 2017 Apr 29.
8
Feasible improvements in vaccines in the Expanded Programme on Immunization.扩大免疫规划中疫苗的可行改进措施。
Rev Infect Dis. 1989 May-Jun;11 Suppl 3:S530-7. doi: 10.1093/clinids/11.supplement_3.s530.
9
Evaluation of the impact of Shandong illegal vaccine sales incident on immunizations in China.评估山东非法疫苗销售事件对中国免疫接种的影响。
Hum Vaccin Immunother. 2018 Jul 3;14(7):1672-1678. doi: 10.1080/21645515.2018.1473697. Epub 2018 Jun 19.
10
Adult immunization. Summary of the National Vaccine Advisory Committee Report.成人免疫接种。国家疫苗咨询委员会报告摘要。
JAMA. 1994 Oct 12;272(14):1133-7. doi: 10.1001/jama.272.14.1133.

引用本文的文献

1
Management of the vaccination campaign in a population of frail older outpatients affected by cognitive or endocrinological conditions: a pilot study in Italy.在患有认知或内分泌疾病的体弱老年门诊患者人群中管理疫苗接种运动:意大利的一项试点研究。
Aging Clin Exp Res. 2024 Aug 30;36(1):179. doi: 10.1007/s40520-024-02824-5.
2
The Problem with Delaying Measles Elimination.推迟消除麻疹的问题。
Vaccines (Basel). 2024 Jul 22;12(7):813. doi: 10.3390/vaccines12070813.
3
Guarding the gatekeepers: a comprehensive approach to control nosocomial measles.
守护守门人:控制医院内麻疹的综合方法。
Infection. 2024 Aug;52(4):1195-1206. doi: 10.1007/s15010-024-02186-0. Epub 2024 Feb 14.
4
Measles surveillance in Canada, 2019.2019年加拿大的麻疹监测
Can Commun Dis Rep. 2021 Mar 31;47(3):149-160. doi: 10.14745/ccdr.v47i03a05.
5
Measles surveillance in Canada: 2018.加拿大2018年麻疹监测
Can Commun Dis Rep. 2020 Apr 2;46(4):77-83. doi: 10.14745/ccdr.v46i04a04.
6
The association between greater continuity of care and timely measles-mumps-rubella vaccination.更高的连续性护理与及时接种麻疹-腮腺炎-风疹疫苗之间的关联。
Am J Public Health. 2000 Jun;90(6):962-5. doi: 10.2105/ajph.90.6.962.
7
Targeting pneumococcal vaccination to high-risk groups: a feasibility study in one general practice.针对高危人群的肺炎球菌疫苗接种:一项全科医疗实践中的可行性研究。
Postgrad Med J. 1999 Apr;75(882):208-12. doi: 10.1136/pgmj.75.882.208.